Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia
Molecular Psychiatry2012Vol. 18(1), pp. 10–11
Citations Over TimeTop 20% of 2012 papers
Jennifer M. Coughlin, K Ishizuka, Shin‐ichi Kano, Jamie A. Edwards, Fayaz Seifuddin, Masako Shimano, Elizabeth L. Daley, Peter P. Zandi, F. Markus Leweke, Nicola G. Cascella, Martin G. Pomper, Robert H. Yolken, Akira Sawa
Related Papers
- → Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis(2002)81 cited
- → Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?(2020)37 cited
- → Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis(2016)28 cited
- → 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice(2022)8 cited
- → A pathological link between dysregulated copper binding in Cu/Zn-superoxide dismutase and amyotrophic lateral sclerosis(2022)2 cited